📷 Image: Wikimedia Commons / Bollywood Hungama
Entertainment
Ajay Devgn's Drishyam 3 Nets ₹3.4 Cr on Day 18, Boosting Domestic Take
✍️ The Times of India
🗓 20 Oct 2026, 05:03 AM
👁 15
The Ajay Devgn-starrer Drishyam 3 added ₹3.4 crore to its domestic box‑office haul on the 18th day of release, according to The Times of India.
The Ajay Devgn‑led thriller Drishyam 3 has continued to perform steadily at the box office, with the latest figures showing an addition of ₹3.4 crore on the 18th day of its theatrical run. The film, which opened to strong audience interest, has maintained a consistent daily intake, reflecting sustained viewer engagement.
While the cumulative domestic gross is not disclosed in the report, the ₹3.4 crore increment underscores the film’s resilience in a competitive market. Analysts note that such a steady daily haul is a positive indicator for the film’s overall profitability.
Industry insiders observe that Drishyam 3’s performance aligns with the trend of successful family dramas in the current cinematic landscape. The film’s ability to attract repeat viewers has been cited as a key factor in its continued earnings.
The Times of India’s update comes as the film approaches its third week, a critical period for many releases. Stakeholders are watching the trajectory closely to gauge the film’s long‑term commercial prospects.
While the cumulative domestic gross is not disclosed in the report, the ₹3.4 crore increment underscores the film’s resilience in a competitive market. Analysts note that such a steady daily haul is a positive indicator for the film’s overall profitability.
Industry insiders observe that Drishyam 3’s performance aligns with the trend of successful family dramas in the current cinematic landscape. The film’s ability to attract repeat viewers has been cited as a key factor in its continued earnings.
The Times of India’s update comes as the film approaches its third week, a critical period for many releases. Stakeholders are watching the trajectory closely to gauge the film’s long‑term commercial prospects.